« Return to News | Awards & Advancement

Perceptive Informatics garners top ratings

Friday, January 20, 2012 03:06 PM

Perceptive Informatics, an eClinical solutions provider and a subsidiary of Parexel International, received top marks for its medical imaging services in an independent survey on the medical imaging market conducted by Blue Pyramid Consulting.

Blue Pyramid's report, which is a source for data on drivers in selecting medical imaging providers for clinical research, surveyed 133 professionals in the biopharmaceutical industry.  Blue Pyramid found Perceptive Informatics medical imaging services were among the top rated of its peers in several attributes including operational excellence, customer service and responsiveness, technology ease of use, value, reputation, management and the ability to bundle other non-imaging services.

Respondents also ranked Perceptive Informatics as one of the providers they will work with in the future. In therapeutic area expertise, Perceptive Informatics received top rankings for its neurology, oncology, cardiology and musculoskeletal therapeutic expertise, as well as in other scientific areas.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.